Uriepero, A., Milano, J., Ziegler, V., Ratnani, A., Varadi, G. (2025). Acalabrutinib vs zanubrutinib as first-line therapy in CLL: A propensity score–matched study. Blood. https://doi.org/10.1182/blood-2025-6333